News

Adam Friedman, MD, FAAD provides insight into how non-medical therapeutic switching affects clinical, economic, and psychological outcomes for patients.

A proposed smartphone-based intervention to address hydroxyurea nonadherence was welcomed by a majority of surveyed individuals with sickle cell disease.

Continuing treatment results in a nearly 8% reduction in weight during a 48 week period.

A dermatologist discusses some of her most common cosmetic practices and techniques.

Closing thoughts on advice to community pediatricians evaluating a baby for spinal muscular atrophy (SMA).

Several spinal muscular atrophy (SMA) resources are suggested to help physicians and families: Cure SMA, SMArt Moves, SMA Standard of Care documents, and the Child Neurology Foundation’s Telehealth Tip Sheet.

Experts suggest what to look for during a virtual examination during COVID-19 that may suggest a diagnosis of spinal muscular atrophy (SMA). If SMA is suspected, they stress the importance of an evaluation, as soon as possible, with a neurologist.

The workflow for a remote visit during COVID-19 is outlined.

Garey H. Noritz, MD, stresses the value of in-person office visits for babies to ensure they receive their vaccinations and physical examination.

The investigators monitored any retinopathy events in hepatitis C patients, including those that were untreated and those being treated with PegIFN/RBV.

Pegcetacoplan, an investigational complement C3 inhibitor, demonstrated superiority to C5 inhibitor, eculizumab, for paroxysmal nocturnal hemoglobinuria.

The therapy could offer a therapeutic option with a better safety profile, investigators said.

Some states are seeing troubling COVID-19 trends in recent weeks.

Scaling-up HCV screening for all inpatients admitted for psychiatric purposes may be more cost-effective compared with a risk-based approach in high-resource countries.

ClearUp Sinus Pain Relief treatment was previously approved for allergy-related sinus and nasal congestion and allergy-related sinus pain.

Sessions show promise helping alleviate stress and concern for COVID-19.

In commemoration of World TB Day, a CDC and ALA expert discuss how TB still exists in the country.

Older age and higher education level were significantly linked with increased depression scores.

The independent DSMB was concerned over the primary efficacy results shared by AstraZeneca in its interim report Monday morning.

Theresa Mallick-Searle, MS, RN-BC, ANP-BC, shares her perspective on the new labeling requirements put forth by the FDA for opioids in regards to naloxone.

Joshua Lynch, DO, EMT-P, FAAEM, FACEP, highlight risks he has seen in the community for unintended users as well as patients for accidental opioid overdose.

The approval is based on results from Phase 3 trials showing high efficacy in adult and pediatric populations.

An expert writes on the scope of the next great COVID-19 vaccine challenge: pediatric assessment and administration.

As a multi-systemic disorder, Fabry disease can impact the functions of various organs. As a genetic disorder, Fabry can impact the offsprings, parents, and relatives of the patient. Therefore, its effects are far-reaching.

The label expansion is for patients aged 6 years and older.

The vaccine was also 100% effective in preventing severe disease.

A literature review identifies 3 broad factors that may contribute to bias in pain management of African Americans with SCD.

Interferon-based therapy is generable intolerable for the older population.